Hepatitis C virus testing of plasma pools by nucleic acid amplification technology: External quality assessment

Vox Sanguinis

Volumn 81, Issue 3, 2001, Pages 143-147

  Gentili, G ^a   Pisani, G ^a   Bisso, G ^a   Cristiano, K ^a   Wirz, M ^a   Mele, C ^a   Mincione, T ^b   Santirocco, N ^b   Streichert, S ^c   Gross, P ^d   Jochum, C ^b   Wadey, C ^b   Johnstone, D ^b   Fang, R ^b   Moretti, E ^b   Barsotti, I ^b   Gajardo, R ^e   Gartner T ^b   Viret, J F ^f   Hertig, C ^f   Stolz, M ^b   Burckhardt, J J ^b   more..

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b Alfa Biotech ^*  (Switzerland)

^c Aventis Behring   (Germany)

^d BAXTER INNOVATIONS GMBH   (Austria)

^e Instituto Grifols   (Spain)

^f Berna Biotech AG   (Switzerland)

Author keywords

Blood products; External quality assessment; HCV RNA; Plasma pool testing

Indexed keywords

ARTICLE; CALIBRATION; EVALUATION; GENE AMPLIFICATION; HEPATITIS C VIRUS; INTERMETHOD COMPARISON; LABORATORY TEST; NUCLEIC ACID AMPLIFICATION; PLASMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITY CONTROL; VALIDATION PROCESS; VIRUS DETECTION;

BLOOD SPECIMEN COLLECTION; DIAGNOSTIC ERRORS; HEPACIVIRUS; HEPATITIS C; HUMANS; ITALY; NUCLEIC ACID AMPLIFICATION TECHNIQUES; OBSERVER VARIATION; QUALITY CONTROL; REAGENT KITS, DIAGNOSTIC; REFERENCE STANDARDS; RNA, VIRAL;

EID: 0035497064     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.2001.00103.x     Document Type: Article

References (9)